Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market by CNBC Markets | March 30, 2026 4:06 am | US Markets U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
